Tesamorelin / Ipamorelin 3mg/2mg/mL/5mL Vial

Tesamorelin / Ipamorelin 3 mg / 2 mg per mL – 5 mL Vial is a compounded peptide formulation designed for research into growth hormone (GH) regulation, metabolism, and body composition. This combination utilizes two growth hormone–releasing peptides to synergistically stimulate endogenous GH secretion via complementary mechanisms. Tesamorelin 3 mg/mL – A synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the anterior pituitary to release GH. It has been investigated for reducing visceral adiposity, improving body composition, and metabolic regulation. Ipamorelin 2 mg/mL – A selective growth hormone secretagogue (GHS) that binds the ghrelin receptor, promoting GH release with minimal effect on cortisol or prolactin levels. Ipamorelin is known for reducing catabolism, supporting lean muscle, and enhancing recovery. A 5 mL vial contains a total of 15 mg Tesamorelin and 10 mg Ipamorelin, intended for subcutaneous injection in controlled research or investigational studies. The combination leverages the complementary actions of a GHRH analog and a GHS to provide a more physiologic stimulation of GH pulses. Mechanism of Tesamorelin and GH regulation: https://pubmed.ncbi.nlm.nih.gov/19151788/ Ipamorelin and selective GH secretion: https://pubmed.ncbi.nlm.nih.gov/19249510/